Grants per year
Personal profile
Certifications and Licenses
| Transplant Hepatology | |
| Gastroenterology |
Training Experience
| 1999 | Residency, University of Chicago Hospitals |
| 2002 | Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Expertise related to UN Sustainable Devlopment Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, MD, University of Illinois at Chicago
… → 1996
Research interests
- Colonoscopy
- Esophagogastroduodenoscopy (EGD)
- Hepatitis
- Liver Biopsy
- Liver/Hepatic Disease
- Non-Alcoholic Fatty Liver Disease
- Variceal Banding
- Viral Hepatitis
Fingerprint
Dive into the research topics where Mary Eugenia Rinella is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot#282-CC-207: Evaluation of Efficacy, Safety and Tolerability of NGM282 (Aldafermin) in a Phase 2b, Randomized, Doubleblind, Placebo-controlled, Multi-center Study in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (ALPINE 4)
Medpace Clinical Research LLC, NGM Biopharmaceuticals, Inc.
12/22/20 → 12/22/23
Project: Research project
-
Prot#EDP 305-102: A Phase 2b Randomized, Double Blind, Placebo-Controlled, Multicenter Study Evaluating Safety and Efficacy of EDP-305 in Subjects with Liver-Biopsy Proven Non-Alcoholic Steatohepatitis (NASH)”
ICON Clinical Research, LLC, Enanta Pharmaceuticals, Inc.
7/31/20 → 7/31/23
Project: Research project
-
Prot#VK2809-202: A Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of VK2809 Administered for 52 Weeks Followed by a 4-Week Off-Drug Phase in Subjects with Biopsy Proven Non-Alcoh
Covance Inc., Viking Therapeutics, Inc.
3/4/20 → 3/4/23
Project: Research project
-
Prot# Aramchol-018: A Phase 3/4, Multinational, Multicenter, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects with Nonalcoholic Steatohepatitis (NASH)
Covance Inc., Galmed Research and Development Ltd.
12/23/19 → 12/23/23
Project: Research project
-
Association between history of bariatric surgery and graft rejection among solid organ transplant recipients
Harrington, C. R., Soghikian, M., Gregory, D., Wilcox, J. E., Shetty, A., Rinella, M. E., Ladner, D. P. & VanWagner, L. B., Mar 2021, In: Transplantation Reports. 6, 1, 100071.Research output: Contribution to journal › Article › peer-review
Open Access -
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis
IDN-6556-17 Study Investigators, Feb 2021, In: Journal of Hepatology. 74, 2, p. 274-282 9 p.Research output: Contribution to journal › Article › peer-review
-
From NAFLD to MAFLD: Implications of a Premature Change in Terminology
Younossi, Z. M., Rinella, M. E., Sanyal, A. J., Harrison, S. A., Brunt, E. M., Goodman, Z., Cohen, D. E. & Loomba, R., Mar 2021, In: Hepatology. 73, 3, p. 1194-1198 5 p.Research output: Contribution to journal › Article › peer-review
47 Scopus citations -
NAFLD: Reporting Histologic Findings in Clinical Practice
for the American Association for the Study of Liver Diseases NASH Task Force, May 2021, In: Hepatology. 73, 5, p. 2028-2038 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access8 Scopus citations -
Non-alcoholic fatty liver disease: Not time for an obituary just yet!
Singh, S. P., Anirvan, P., Reddy, K. R., Conjeevaram, H. S., Marchesini, G., Rinella, M. E., Madan, K., Petroni, M. L., Al-Mahtab, M., Caldwell, S. H., Aithal, G. P., Hamid, S. S., Farrell, G. C., Satapathy, S. K., Duseja, A., Acharya, S. K., Dassanayake, A. S. & Goh, K. L., Apr 2021, In: Journal of Hepatology. 74, 4, p. 972-974 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access5 Scopus citations